|Master Investor Magazine
Never miss an issue of Master Investor Magazine – sign-up now for free!
AIM-listed digital chemistry software developer DeepMatter (LON:DMTR) has recorded the first revenues for its DigitalGlassware platform. The company has signed a deal to provide additional user licences to an Anglo-Indian medicinal chemistry services provider that participated in its pioneer programme.
CEO Mark Warne commented: “This is a key milestone for the Company, and we are delighted that o2h has progressed from our Pioneer Programme to deploying DigitalGlassware™ across one of its laboratories. This deal demonstrates that our platform is delivering tangible value to the industry and the fact that o2h, renowned for being innovative and forward thinking, is the first of our partners to sign a contract of this nature with us, underlines the disruptive potential of our platform.
“This is the first step on our journey towards monetisation of the platform in line with our current expectations“.
DeepMatter shares fell by 3.23% to 3p (as of 11:00 BST).